We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.9B
1-Year Est. Return 39.77%
This Fund
S&P 500
This Quarter Est. Return
+6.84%
1 Year Est. Return
+39.77%
3 Year Est. Return
+108.07%
5 Year Est. Return
+139.85%
10 Year Est. Return
+551.6%
AUM
$381M
AUM Growth
+$32.8M
Cap. Flow
+$11.8M
Cap. Flow %
3.11%
Top 10 Hldgs %
19.11%
Holding
360
New
48
Increased
19
Reduced
17
Closed
8

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.21M
2
AVGO icon
Broadcom
AVGO
+$1.67M
3
PSX icon
Phillips 66
PSX
+$719K
4
EL icon
Estee Lauder
EL
+$618K
5
CL icon
Colgate-Palmolive
CL
+$437K

Sector Composition

Rank Sector Weight
1 Technology 17.07%
2 Financials 16.46%
3 Healthcare 15.79%
4 Communication Services 11.07%
5 Consumer Discretionary 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
26
Cisco
CSCO
$436B
$3.15M 0.83%
93,175
IBM icon
27
IBM
IBM
$224B
$3.03M 0.8%
18,217
OXY icon
28
Occidental Petroleum
OXY
$59.3B
$2.8M 0.74%
44,205
+850
+2% +$56.5K
AMGN icon
29
Amgen
AMGN
$206B
$2.77M 0.73%
16,883
ORCL icon
30
Oracle
ORCL
$453B
$2.76M 0.73%
61,958
COP icon
31
ConocoPhillips
COP
$159B
$2.64M 0.69%
52,884
+4,490
+9% +$217K
DHR icon
32
Danaher
DHR
$149B
$2.61M 0.69%
34,409
ABBV icon
33
AbbVie
ABBV
$463B
$2.6M 0.68%
39,974
MCD icon
34
McDonald's
MCD
$176B
$2.6M 0.68%
20,090
USB icon
35
US Bancorp
USB
$94.1B
$2.29M 0.6%
44,532
ABT icon
36
Abbott
ABT
$176B
$2.28M 0.6%
51,251
+5,849
+13% +$253K
MDT icon
37
Medtronic
MDT
$119B
$2.27M 0.6%
+28,240
New +$2.21M
MA icon
38
Mastercard
MA
$497B
$2.26M 0.59%
20,125
WMT icon
39
Walmart Inc
WMT
$847B
$2.23M 0.58%
92,673
ACN icon
40
Accenture
ACN
$116B
$2.21M 0.58%
18,443
LLY icon
41
Eli Lilly
LLY
$1.02T
$2.21M 0.58%
26,265
WM icon
42
Waste Management
WM
$85B
$2.12M 0.56%
29,102
PX
43
DELISTED
Praxair Inc
PX
$2.04M 0.54%
17,225
CVS icon
44
CVS Health
CVS
$117B
$2.04M 0.54%
26,003
UNP icon
45
Union Pacific
UNP
$167B
$2.01M 0.53%
18,964
LOW icon
46
Lowe's Companies
LOW
$109B
$1.96M 0.52%
23,877
CL icon
47
Colgate-Palmolive
CL
$69.6B
$1.93M 0.51%
26,383
+6,250
+31% +$437K
BMY icon
48
Bristol-Myers Squibb
BMY
$129B
$1.89M 0.5%
34,674
CELG
49
DELISTED
Celgene Corp
CELG
$1.87M 0.49%
15,030
SBUX icon
50
Starbucks
SBUX
$111B
$1.85M 0.49%
31,676

Similar funds

Everence Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Everence Capital Management held 360 positions worth $381M, up 9.4% from $348M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Everence Capital Management deployed $11.8M of net new capital in Q1 2017, opening 48 new positions and adding to 19 existing holdings. Its largest new stake was Medtronic: 28,240 shares worth $2.27M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was 3M, an estimated $244K trimmed.

  • Everence Capital Management's largest Q1 2017 buy was Medtronic: 28,240 shares worth $2.27M.
  • Everence Capital Management added most to Phillips 66 in Q1 2017, an estimated $719K increase.
  • Everence Capital Management's biggest Q1 2017 reduction was 3M, cutting an estimated $244K.
  • Everence Capital Management fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $1.02M.
  • Everence Capital Management's ten largest holdings make up 19% of its $381M portfolio in Q1 2017.
  • Everence Capital Management opened 48 new positions and closed 8 in Q1 2017.
  • Everence Capital Management's portfolio value rose 9.4% quarter-over-quarter to $381M.

Based on Everence Capital Management's 13F filing for Q1 2017, filed 19 Apr 2017.